Yocca Frank 4
4 · BioXcel Therapeutics, Inc. · Filed Aug 5, 2025
Insider Transaction Report
Form 4
Yocca Frank
Chief Scientific Officer
Transactions
- Award
Restricted Stock Units
2025-08-01+9,000→ 9,000 total→ Common Stock (9,000 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]On August 1, 2025 (the "Grant Date"), the Reporting Person was granted 9,000 RSUs, vesting as to 100% on or within thirty (30) days of 9 months from the Grant Date, subject to the Reporting Person's continued employment with the Issuer or a subsidiary of the Issuer on such date.